|
1
|
Parekh JD, Kukrety S, Thandra A and
Valenta C: Multiple primary malignant neoplasms in an elderly
patient. Cureus. 10:e23842018.PubMed/NCBI
|
|
2
|
Pan SY, Huang CP and Chen WC:
Synchronous/Metachronous multiple primary malignancies: Review of
associated risk factors. Diagnostics (Basel). 12:19402022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ye X, Liu X, Yin N, Song W, Lu J, Yang Y
and Chen X: Successful first-line treatment of simultaneous
multiple primary malignancies of lung adenocarcinoma and renal
clear cell carcinoma: A case report. Front Immunol. 13:9565192022.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Motuzyuk I, Sydorchuk O, Kovtun N, Palian
Z and Kostiuchenko Y: Analysis of trends and factors in breast
multiple primary malignant neoplasms. Breast Cancer (Auckl).
12:11782234187599592018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilson ML, Ayers S, Berney D, Eslan A,
Guarner J, Lester S, Masia R, Moloo Z, Mutuku A, Roberts D, et al:
Improving anatomic pathology in sub-saharan africa to support
cancer care. Am J Clin Pathol. 149:310–315. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chai W, Gong F, Zhang W, Wen Y and Cui L:
Multiple primary cancer in the female genital system: Two rare case
reports and a literature review. Medicine (Baltimore).
96:e88602017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bai J, Xie Z and Sun L: Case report:
Metachronous quadruple cancers including breast cancer and triple
genital cancer. Int J Gen Med. 13:1575–1580. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Borja NA, Silva-Smith R, Calfa C, Sussman
DA and Tekin M: Triple primary cancers: An analysis of genetic and
environmental factors. Cancer Prev Res (Phila). 17:209–215. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang P, Tan X, Chen C, Lv X and Li Y:
AF-SENet: Classification of cancer in cervical tissue pathological
images based on fusing deep convolution features. Sensors (Basel).
21:1222020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Solal-Celigny P, Roy P, Colombat P, White
J, Armitage JO, Arranz-Saez R, Au WY, Bellei M, Brice P, Caballero
D, et al: Follicular lymphoma international prognostic index.
Blood. 104:1258–1265. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Boughan KM and Caimi PF: Follicular
lymphoma: Diagnostic and prognostic considerations in initial
treatment approach. Curr Oncol Rep. 21:632019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smith SM: Dissecting follicular lymphoma:
High versus low risk. Hematology Am Soc Hematol Educ Program.
2013:561–567. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saleh M, Virarkar M, Javadi S, Elsherif
SB, de Castro Faria S and Bhosale P: Cervical cancer: 2018 revised
international federation of gynecology and obstetrics staging
system and the role of imaging. AJR Am J Roentgenol. 214:1182–1195.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zelenetz AD, Gordon LI, Abramson JS,
Advani RH, Andreadis B, Bartlett NL, Budde LE, Caimi PF, Chang JE,
Christian B, et al: NCCN Guidelines® Insights: B-Cell
Lymphomas, Version 6.2023. J Natl Compr Canc Netw. 21:1118–1131.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abu-Rustum NR, Yashar CM, Bean S, Bradley
K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, et al:
NCCN guidelines insights: Cervical cancer, version 1.2020. J Natl
Compr Canc Netw. 18:660–666. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo JQ, Zou JJ, Zhu JD, Jiang C and Shao
CX: A case report of rectal adenocarcinoma with intrahepatic
cholangiocarcinoma of the liver. J Int Med Res. 47:5883–5890. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Warren S and Gates O: Multiple primary
malignant tumors: A survey of the literature and a statistical
study. Am J Cancer. 16:1358–1414. 1932.
|
|
18
|
Yang YH, Deng Q, Yang TB, Gui Y, Zhang YX,
Liu JB, Deng Q, Liu WF and Sun JJ: A case report of
cholangiocarcinoma combined with moderately differentiated gastric
adenocarcinoma. Medicine (Baltimore). 98:e163322019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou S, Lu Z, Wu H, Gu CY, Zhang DY, Sun
WL, Ma X and Liu HC: Synchronous multiple primary gallbladder and
gastric malignancies: Report of two cases and review of the
literature. Mol Clin Oncol. 7:869–873. 2017.PubMed/NCBI
|
|
20
|
Liu Y, Yang H, Fu X, Zhong L, Xu P, Fang
F, Liu Y, Li Q, Yan Y, Wei S, et al: BRCA2, PALB2, RECQL4 germline
pathogenic variants, and somatic TP53 mutation in triple
metachronous malignancies: A case report and literature review. Int
Med Case Rep J. 17:23–29. 2024.PubMed/NCBI
|
|
21
|
Hiyama T and Fujimoto I: Epidemiological
studies on multiple primary cancers-observations on the second
primary cancers among cervical cancer and laryngeal cancer cases.
Gan No Rinsho. 30:1499–1506. 1984.(In Japanese). PubMed/NCBI
|
|
22
|
Semczuk A, Colas E, Walczyna B, Joźwik M,
Pyra A, Semczuk-Sikora A and Rechberger T: Coexistence of
homologous-type cervical carcinosarcoma with endometrioid-type G1
endometrial cancer: A case report with an immunohistochemical
study. Int J Clin Exp Pathol. 7:7191–7195. 2014.PubMed/NCBI
|
|
23
|
Studzinski Z, Filipczak A and Branicka D:
Coexistence of ovarian adenocarcinoma with tubal pregnancy and
plano-epithelial cervical cancer of uterus. Ginekol Pol.
69:805–808. 1998.(In Polish). PubMed/NCBI
|
|
24
|
Lee YC, Lee YL and Li CY: BRCA genes and
related cancers: A Meta-analysis from epidemiological cohort
studies. Medicina (Kaunas). 57:9052021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wen W, Chen WS, Xiao N, Bender R,
Ghazalpour A, Tan Z, Swensen J, Millis SZ, Basu G, Gatalica Z and
Press MF: Mutations in the kinase domain of the HER2/ERBB2 gene
identified in a wide variety of human cancers. J Mol Diagn.
17:487–495. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kajitani N, Glahder J, Wu C, Yu H, Nilsson
K and Schwartz S: hnRNP L controls HPV16 RNA polyadenylation and
splicing in an Akt kinase-dependent manner. Nucleic Acids Res.
45:9654–9678. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cho EH, Park MS, Woo HY, Park H and Kwon
MJ: Evaluation of clinical usefulness of HPV-16 and HPV-18
genotyping for cervical cancer screening. J Gynecol Oncol.
35:e722024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Murray PG and Young LS: An etiological
role for the Epstein-Barr virus in the pathogenesis of classical
Hodgkin lymphoma. Blood. 134:591–596. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Akagi K, Symer DE, Mahmoud M, Jiang B,
Goodwin S, Wangsa D, Li Z, Xiao W, Dunn JD, Ried T, et al:
Intratumoral heterogeneity and clonal evolution induced by HPV
integration. Cancer Discov. 13:910–927. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ren X, Cheng Y, Wu S, Zeng X, Shi X, Ling
Q, Li Z, Liang Z and Wang B: Primary non-Hodgkin lymphoma of the
tongue base: The clinicopathology of seven cases and evaluation of
HPV and EBV status. Diagn Pathol. 15:302020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang JT, Liu CZ, Domer P and Iannaccone P:
Expression of lymphomagenic oncogenes in T-cell lymphomas of HPV 16
transgenic mice. Cancer Detect Prev. 22:405–415. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Toner K, McCann CD and Bollard CM:
Applications of cell therapy in the treatment of virus-associated
cancers. Nat Rev Clin Oncol. 21:709–724. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grigsby PW, Massad LS, Mutch DG, Powell
MA, Thaker PH, McCourt C, Hagemann A, Fuh K, Kuroki L, Schwarz JK,
et al: FIGO 2018 staging criteria for cervical cancer: Impact on
stage migration and survival. Gynecol Oncol. 157:639–643. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kostov S, Kornovski Y, Slavchev S, Ivanova
Y, Dzhenkov D, Dimitrov N and Yordanov A: Pelvic Lymphadenectomy in
gynecologic Oncology-significance of anatomical variations.
Diagnostics (Basel). 11:892021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Saeteng S, Tantraworasin A, Euathrongchit
J, Lertprasertsuke N and Wannasopha Y: Nodal involvement pattern in
resectable lung cancer according to tumor location. Cancer Manag
Res. 4:151–158. 2012.PubMed/NCBI
|
|
37
|
Suzuki R, Nakata K, Okamura S, Kanemura T,
Yanai A, Kobayashi M, Yoshioka Y, Uji K, Yoshida A, Takeno A, et
al: Case report-a long-term surviving patient who received lymph
node dissection of skip metastasis from rectosigmoid cancer to
bilateral lateral lymph nodes. Gan To Kagaku Ryoho. 37:2598–2600.
2010.(In Japanese). PubMed/NCBI
|
|
38
|
Bertelsen CA, Kirkegaard-Klitbo A, Nielsen
M, Leotta SM, Daisuke F and Gogenur I: Pattern of colon cancer
lymph node metastases in patients undergoing central mesocolic
lymph node excision: A systematic review. Dis Colon Rectum.
59:1209–1221. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao L, Wu F, Zhou T, Lu K, Jiang K, Zhang
Y and Luo D: Risk factors of skip lateral cervical lymph node
metastasis in papillary thyroid carcinoma: A systematic review and
Meta-analysis. Endocrine. 75:351–359. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Brunette LL, Bonyadlou S, Ji L, Groshen S,
Shuster D, Mehta A, Sposto R, Matsuo K, Lin YG and Roman LD:
Predictive value of FDG PET/CT to detect lymph node metastases in
cervical cancer. Clin Nucl Med. 43:793–801. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Khebbeb S, Rathat G, Serrand C, Bourdon A,
Ferrer C and Duraes M: Interest of para-aortic lymphadenectomy for
locally advanced cervical cancer in the era of PET scanning. Eur J
Obstet Gynecol Reprod Biol. 272:234–239. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Abu-Rustum NR, Yashar CM, Arend R, Barber
E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA,
et al: NCCN Guidelines® Insights: Cervical Cancer,
Version 1.2024. J Natl Compr Canc Netw. 21:1224–1233. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sedlis A, Bundy BN, Rotman MZ, Lentz SS,
Muderspach LI and Zaino RJ: A randomized trial of pelvic radiation
therapy versus no further therapy in selected patients with stage
IB carcinoma of the cervix after radical hysterectomy and pelvic
lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol.
73:177–183. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huang H, Feng YL, Wan T, Zhang YN, Cao XP,
Huang YW, Xiong Y, Huang X, Zheng M, Li YF, et al: Effectiveness of
sequential chemoradiation vs concurrent chemoradiation or radiation
alone in adjuvant treatment after hysterectomy for cervical cancer:
The STARS phase 3 randomized clinical trial. JAMA Oncol. 7:361–369.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Saleem T, Mi K, Pathak R, Yari K and Lu K:
Concurrent breast carcinoma and follicular lymphoma: A case series.
Am J Case Rep. 22:e9317722021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhu Z, Zhou N, Yu S, Gao X, Cheng X, Wang
Y and Bai C: Successful treatment of concurrent follicular lymphoma
and Triple-negative breast cancer using rituximab plus
Nab-paclitaxel and cisplatin: A case report and literature review.
Onco Targets Ther. 16:905–911. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Marumo Y, Kusumoto S, Masaki A, Nakashima
T, Kikuchi T, Mori F, Komatsu H, Inagaki H, Iida S and Inagaki A:
Newly diagnosed follicular lymphoma during pembrolizumab treatment
for lung cancer. Int J Hematol. 114:280–285. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hahm MH, Kim HJ, Shin KM, Cho SH, Park JY,
Jung JH, Jeong JY and Bae JH: Concurrent invasive ductal carcinoma
of the breast and malignant follicular lymphoma, initially
suspected to be metastatic breast cancer: A case report. J Breast
Cancer. 17:91–97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rosler W, Altenbuchinger M, Baeßler B,
Beissbarth T, Beutel G, Bock R, von Bubnoff N, Eckardt JN, Foersch
S, Loeffler CML, et al: An overview and a roadmap for artificial
intelligence in hematology and oncology. J Cancer Res Clin Oncol.
149:7997–8006. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tanjak P, Suktitipat B, Vorasan N,
Juengwiwattanakitti P, Thiengtrong B, Songjang C, Therasakvichya S,
Laiteerapong S and Chinswangwatanakul V: Risks and cancer
associations of metachronous and synchronous multiple primary
cancers: A 25-year retrospective study. BMC Cancer. 21:10452021.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu S, Jia Y, Chai J, Ge H, Huang R, Li A
and Cheng H: A predictive model for the early death of breast
cancer with synchronous liver metastases: A Population-based study.
Cancer Control. 30:107327482312028512023. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pilarski R, Patel DA, Weitzel J, McVeigh
T, Dorairaj JJ, Heneghan HM, Miller N, Weidhaas JB, Kerin MJ,
McKenna M, et al: The KRAS-variant is associated with risk of
developing double primary breast and ovarian cancer. PLoS One.
7:e378912012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cvelbar M, Hocevar M, Vidmar G and Teugels
E: BRCA1/2 status and clinicopathologic characteristics of patients
with double primary breast and ovarian cancer. Neoplasma.
58:198–204. 2011. View Article : Google Scholar : PubMed/NCBI
|
